ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET FORECAST 2019-2027
The Asia Pacific Point of care diagnostic market was valued at $XX million in 2018 and is expected to reach $XX million by 2027 with a CAGR of 10.82% during the forecast period of 2019-2027. POC diagnostic procedures are carried out by various POC diagnostic devices, which are used to test cholesterol and glucose levels, enzyme analysis, drugs of abuse testing, diagnosis of infectious diseases, and pregnancy testing.
ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET FORECAST 2019-2027
Asia Pacific Point of Care Diagnostics Market by Mode of Prescription (Prescription Based Devices, Otc Based Devices) by End-user (Professional Diagnostic Centers, Research Laboratories, Home Care, Other End-user) by Product Type (Glucose Monitoring Kits, Infectious Diseases Testing Kits, Pregnancy and Fertility Testing Kits, Hematology Testing Kits, Cardiometabolic Monitoring Kits, Urinalysis Testing Kits, Coagulation Monitoring Kits, Tumor/cancer Markers Testing Kits, Cholesterol Testing Trips, Drugs of Abuse Testing Kits, Fecal Occult Testing Kits, Other Product) by Geography.
The Point of care diagnostic (POC) tests refers to the diagnostic procedures, which are conducted outside the laboratories. POC diagnostic procedures are carried out by various POC diagnostic devices, which are used to test cholesterol and glucose levels, enzyme analysis, drugs of abuse testing, diagnosis of infectious diseases, and pregnancy testing.
The Asia Pacific Point of care diagnostic market was valued at $XX million in 2018 and is expected to reach $XX million by 2027 with a CAGR of 10.82% during the forecast period of 2019-2027.
The countries like China, India, Japan, South Korea and Australia are considered fr the market analysis. Factors such as limited resource usability coupled with increasing prevalence rates, and technological advancements, are the major drivers in Asia Pacific segment of point of care testing market which is expected to witness the fastest growth over the forecast period. Japan is one of the largest market for in vitro diagnostics and the popularity of point of care testing has increased due to the focus towards benefits of in vitro diagnostics.
Furthermore, growing patient population base, ongoing developments, private-public collaborations, and government initiatives have offered immense opportunities for the progress of the Asian market. However, making a point of care testing devices available to the rural base in the developing countries of the region is still a task. Demand for more precise and accurate affordable devices is expected to drive the growth of the market.
F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Bio-Rad Laboratories, Inc., Biomérieux SA, Danaher Corporation, Abbott, Chembio Diagnost ICS Systems, Inc., Becton Dickinson and Company, Gene POC, Trinity Biotech, Siemens Healthineers, Trivitron Healthcare, Sight Diagnostics Ltd., Ortho Clinical Diagnostics, and Cardinal Health Inc. are the major companies.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- INFECTIOUS DISEASE TESTING KIT IS THE FASTEST GROWING PRODUCT TYPE DURING THE FORECAST PERIOD
- PROFESSIONAL DIAGNOSTIC CENTERS ARE THE MAJOR END USER IN POINT OF CARE MARKET
- PRESCRIPTION BASED DEVICES ARE THE FREQUENTLY USED MODE OF PRESCRIPTION
- MARKET DYNAMICS
- MARKET SCOPE & DEFINITION
- MARKET DRIVERS
- GROWING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES
- RISE IN THE IMPLEMENTATION OF HEALTHCARE REFORMS
- RISING DEMAND FOR DECENTRALIZED CHRONIC AND INFECTIOUS DISEASE TESTING
- MARKET RESTRAINTS
- STRINGENT REGULATION
- INSUFFICIENT REIMBURSEMENT POLICIES
- MARKET OPPORTUNITIES
- REDUCTION IN THE HEALTHCARE COST FACILITATES
- RISING INCIDENCES AND PREVALENCE RATES OF VARIOUS INFECTIOUS DISEASES
- GROWING NUMBER OF SMARTPHONE EMPOWERS PATIENTS TO MONITOR THEIR CLINICAL CONDITION ONLINE
- MARKET CHALLENGES
- CHALLENGES RELATED TO THE EXECUTION OF HIGHLY SENSITIVE DEVICES
- VARIATION IN TEST RESULTS
- DIFFICULTIES ASSOCIATED IN DATA MANAGEMENT
- MARKET BY MODE OF PRESCRIPTION
- PRESCRIPTION BASED DEVICES
- OTC BASED DEVICES
- MARKET BY END USER
- PROFESSIONAL DIAGNOSTIC CENTERS
- RESEARCH LABORATORIES
- HOME CARE
- OTHER END USER
- MARKET BY PRODUCT TYPE
- GLUCOSE MONITORING KITS
- INFECTIOUS DISEASES TESTING KITS
- PREGNANCY AND FERTILITY TESTING KITS
- HEMATOLOGY TESTING KITS
- CARDIOMETABOLIC MONITORING KITS
- URINALYSIS TESTING KITS
- COAGULATION MONITORING KITS
- TUMOR/CANCER MARKERS TESTING KITS
- CHOLESTEROL TESTING TRIPS
- DRUGS OF ABUSE TESTING KITS
- FECAL OCCULT TESTING KITS
- OTHER PRODUCT
- KEY ANALYTICS
- PORTER’S FIVE FORCES MODEL
- THREAT OF NEW ENTRANTS
- THREAT OF SUBSTITUTE
- BARGAINING POWER OF BUYERS
- BARGAINING POWER OF SUPPLIERS
- THREAT OF COMPETITIVE RIVALRY
- POLITICAL & LEGAL, ECONOMIC AND TECHNOLOGICAL ANALYSIS
- REGULATORY FRAMEWORK
- PATENT ANALYSIS
- ETYMOLOGY OF POINT OF CARE MARKET
- OPPORTUNITY MATRIX
- PORTER’S FIVE FORCES MODEL
- GEOGRAPHICAL ANALYSIS
- ASIA PACIFIC
- JAPAN
- CHINA
- INDIA
- AUSTRALIA
- SOUTH KOREA
- REST OF ASIA PACIFIC
- ASIA PACIFIC
- COMPANY PROFILES
- ABBOTT
- BECTON DICKINSON AND COMPANY
- BIOMÉRIEUX SA
- BIO-RAD LABORATORIES, INC.
- CARDINAL HEALTH INC.
- CHEMBIO DIAGNOST ICS SYSTEMS, INC.
- DANAHER CORPORATION
- GENE POC
- HOFFMANN-LA ROCHE LTD.
- ORTHO CLINICAL DIAGNOSTICS
- QUEST DIAGNOSTICS INC.
- SIEMENS HEALTHINEERS
- SIGHT DIAGNOSTICS LTD.
- THERMO FISHER SCIENTIFIC INC.
- TRINITY BIOTECH
- TRIVITRON HEALTHCARE
LIST OF TABLES
TABLE 1 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
TABLE 2 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY MODE OF PRESCRIPTION 2019-2027 ($ MILLION)
TABLE 3 ASIA PACIFIC PRESCRIPTION BASED DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 4 ASIA PACIFIC OTC BASED DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 5 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 6 ASIA PACIFIC PROFESSIONAL DIAGNOSTIC CENTERS MARKET 2019-2027 ($ MILLION)
TABLE 7 ASIA PACIFIC RESEARCH LABORATORIES MARKET 2019-2027 ($ MILLION)
TABLE 8 ASIA PACIFIC HOME CARE MARKET 2019-2027 ($ MILLION)
TABLE 9 ASIA PACIFIC OTHER END USER MARKET 2019-2027 ($ MILLION)
TABLE 10 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY PRODUCT TYPE 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC GLUCOSE MONITORING KITS MARKET 2019-2027 ($ MILLION)
TABLE 12 ASIA PACIFIC INFECTIOUS DISEASES TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 13 ASIA PACIFIC PREGNANCY AND FERTILITY TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 14 ASIA PACIFIC HEMATOLOGY TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 15 ASIA PACIFIC CARDIOMETABOLIC MONITORING KITS MARKET 2019-2027 ($ MILLION)
TABLE 16 ASIA PACIFIC URINALYSIS TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 17 ASIA PACIFIC COAGULATION MONITORING KITS MARKET 2019-2027 ($ MILLION)
TABLE 18 ASIA PACIFIC TUMOR/CANCER MARKERS TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 19 ASIA PACIFIC CHOLESTEROL TESTING TRIPS MARKET 2019-2027 ($ MILLION)
TABLE 20 ASIA PACIFIC DRUGS OF ABUSE TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 21 ASIA PACIFIC FECAL OCCULT TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 22 ASIA PACIFIC OTHER PRODUCT MARKET 2019-2027 ($ MILLION)
TABLE 23 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY COUNTRY 2019-2027 ($ MILLION)
LIST OF FIGURES
FIGURE 1 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
FIGURE 2 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET SHARE BY MODE OF PRESCRIPTION 2018 & 2027 (%)
FIGURE 3 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY PRESCRIPTION BASED DEVICES 2019-2027 ($ M 2019-2027ILLION)
FIGURE 4 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY OTC BASED DEVICES 2019-2027 ($ MILLION)
FIGURE 5 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET SHARE BY END USER 2018 & 2027 (%)
FIGURE 6 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY PROFESSIONAL DIAGNOSTIC CENTERS 2019-2027 ($ MILLION)
FIGURE 7 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY RESEARCH LABORATORIES 2019-2027 ($ MILLION)
FIGURE 8 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY HOME CARE 2019-2027 ($ MILLION)
FIGURE 9 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY OTHER END USER 2019-2027 ($ MILLION)
FIGURE 10 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET SHARE BY PRODUCT TYPE 2018 & 2027 (%)
FIGURE 11 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY GLUCOSE MONITORING KITS 2019-2027 ($ MILLION)
FIGURE 12 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY INFECTIOUS DISEASES TESTING KITS 2019-2027 ($ MILLION)
FIGURE 13 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY PREGNANCY AND FERTILITY TESTING KITS 2019-2027 ($ MILLION)
FIGURE 14 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY HEMATOLOGY TESTING KITS 2019-2027 ($ MILLION)
FIGURE 15 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY CARDIOMETABOLIC MONITORING KITS 2019-2027 ($ MILLION)
FIGURE 16 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY URINALYSIS TESTING KITS 2019-2027 ($ MILLION)
FIGURE 17 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY COAGULATION MONITORING KITS 2019-2027 ($ MILLION)
FIGURE 18 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY TUMOR/CANCER MARKERS TESTING KITS 2019-2027 ($ MILLION)
FIGURE 19 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY CHOLESTEROL TESTING TRIPS 2019-2027 ($ MILLION)
FIGURE 20 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY DRUGS OF ABUSE TESTING KITS 2019-2027 ($ MILLION)
FIGURE 21 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY FECAL OCCULT TESTING KITS 2019-2027 ($ MILLION)
FIGURE 22 ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY OTHER PRODUCT 2019-2027 ($ MILLION)
FIGURE 23 PORTER’S FIVE FORCE MODEL
FIGURE 24 JAPAN POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
FIGURE 25 CHINA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
FIGURE 26 INDIA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
FIGURE 27 AUSTRALIA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
FIGURE 28 SOUTH KOREA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
FIGURE 29 REST OF ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
- GEOGRAPHICAL ANALYSIS
- ASIA PACIFIC
- JAPAN
- CHINA
- INDIA
- AUSTRALIA
- SOUTH KOREA
- REST OF ASIA PACIFIC
- ASIA PACIFIC
- MARKET BY MODE OF PRESCRIPTION
- PRESCRIPTION BASED DEVICES
- OTC BASED DEVICES
- MARKET BY END USER
- PROFESSIONAL DIAGNOSTIC CENTERS
- RESEARCH LABORATORIES
- HOME CARE
- OTHER END USER
- MARKET BY PRODUCT TYPE
- GLUCOSE MONITORING KITS
- INFECTIOUS DISEASES TESTING KITS
- PREGNANCY AND FERTILITY TESTING KITS
- HEMATOLOGY TESTING KITS
- CARDIOMETABOLIC MONITORING KITS
- URINALYSIS TESTING KITS
- COAGULATION MONITORING KITS
- TUMOR/CANCER MARKERS TESTING KITS
- CHOLESTEROL TESTING TRIPS
- DRUGS OF ABUSE TESTING KITS
- FECAL OCCULT TESTING KITS
- OTHER PRODUCT
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.